ESG-aligned indices in Asean outperform conventional benchmarks: CGS International
[SINGAPORE] Stock market indices that include South-east Asian companies screened for their environmental, social and governance (ESG) practices tend to outperform their conventional benchmarks, said a recent report by financial services provider CGS International.
This indicates that the premium Asean companies can get from strong ESG performance – whether through higher valuations, lower costs of capital or better investor sentiment – has matured into a structural signal rather than a transient recovery, the report noted.
The report found that between May 2022 and May 2025, the ESG-aligned index FTSE4Good Asean 5 generated an annualised return of 5.1 per cent, and achieved a 3.6 per cent alpha against the FTSE Asean All-Share Index.
Similarly, the FTSE4Good Bursa Malaysia had an annualised return of 3.5 per cent over the same period, and outperformed the FTSE Bursa Malaysia EMAS index by 0.4 per cent.
'This hints that ESG momentum is no longer a lagging catch-up. It is now a repeatable source of risk-adjusted alpha, especially when integrated into capital allocation decisions,' said the report.
ESG performers and laggards
Regulatory momentum in Asean – such as the growing number of mandatory sustainability reporting requirements – as well as better transparency in ESG scoring systems, are leading investors to price ESG performers structurally, and penalise laggards as part of their Asean strategy.
A NEWSLETTER FOR YOU
Friday, 12.30 pm ESG Insights
An exclusive weekly report on the latest environmental, social and governance issues.
Sign Up
Sign Up
Research shows that Asean stocks with low ESG risk delivered positive returns in several markets over a three-year horizon.
In Malaysia and Thailand, for example, companies with clear ESG transition pathways and consistent disclosure momentum outpaced their country indices. Institutional investors in these markets have also expressed a growing preference for sustainability-aligned portfolios for downside protection and structural exposure to regulatory and thematic tailwinds.
Similarly, poor ESG performance now carries visible commercial and financial consequences. The reported noted that companies in Malaysia, Vietnam and Indonesia have faced import bans and exclusion from global supply chains due to labour or environmental violations.
Beyond reputational risks, companies with ESG controversies also face capital market penalties as they contend with higher risk premiums in bond pricing and less access to ESG-linked lending.
With local regulators such as those in Indonesia trying to mandate ESG integration into credit risk evaluation and Philippines banks having to report on ESG-linked capital allocation from this year, the financing costs for ESG laggards will inevitably go up.
'The cost of non-alignment is enforced through both market mechanisms and institutional standards. Sustainability blind spots, once overlooked, are now being priced into both trade and capital costs,' said the report.
'This shift marks a reassertion of the ESG premium through improved data quality, risk-adjusted performance and investor alignment. Where ESG was once overlooked due to insufficient signal fidelity, credible transitions and regulation-backed disclosures are now enabling that premium to be priced in,' it added.
Asean companies are also not just adopting ESG strategies to meet basic disclosure compliance, but are leveraging ESG to differentiate their business models, and deepen investor engagement.
For example, Indonesia's Bank Central Asia aligned its credit allocation with ESG principles, excluded borrowers involved in unsustainable sectors and increased its green loan portfolio to 23 per cent of total lending in mid-2024.
'ESG is now guiding capital allocation decisions, reshaping business portfolios and offering visibility to long-term investors seeking resilience and transition alignment. This transition from reporting to repositioning strengthens the ESG alpha thesis, particularly in sectors with high regulatory exposure and stakeholder sensitivity,' said the report.
Integrating ESG into equity allocation
Beside supportive regulation, this gradual repositioning of ESG investing is a result of it being initially seen as a specialist approach into a structural allocation theme over the last three years, with institutional asset owners increasingly embedding ESG into mandates, and rebalancing equity allocation based on ESG transitions.
Malaysia's retirement savings fund Employees Provident Fund, Singapore's state investor Temasek, as well as Thailand's Government Pension Fund have actively tilted their portfolios towards ESG improvers.
Allocation decisions are increasingly based on ESG trajectory signals, particularly those tied to climate reporting upgrades, governance remediation and sector-specific policy responsiveness. These trends underscore a shift in practice that ESG momentum is no longer aspirational, but already embedded in active capital allocation decisions.
'This convergence in investor behaviour and regulatory architecture ensures that ESG remains an embedded, credible theme in global capital markets. These trends create a structural tailwind for ESG-integrated portfolios, particularly in under-covered or inefficient markets where mispriced ESG momentum can generate alpha,' said the report.
Investors in Asean should therefore approach ESG integration as a structured signal used to enhance selectivity and allocate into companies exhibiting both transition visibility and valuation headroom.
Despite the growing ESG momentum in South-east Asia, the report also highlighted several risks to watch out for.
These are inconsistent disclosures and regulatory divergence across the region; superficial compliance; execution gaps when implementing ESG strategies; as well as ESG scoring instability due to changes in methodologies.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Independent Singapore
17 hours ago
- Independent Singapore
China rolls out 5-year multi-entry 'ASEAN visa' for business travellers
Photo: Depositphotos/ronniechua SINGAPORE: Business travellers from the 10 ASEAN (Association of Southeast Asian Nations) countries and ASEAN observer Timor-Leste will now have access to a five-year multiple-entry 'ASEAN visa', with each visit lasting up to 180 days, Channel News Asia reported, citing China's foreign ministry announcement on Tuesday. The visa will be available to eligible travellers, along with their spouses and children, from ASEAN member states, including Indonesia, Malaysia, the Philippines, Singapore, Thailand, Brunei, Vietnam, Laos, Myanmar, and Cambodia, as well as Timor-Leste. According to Chinese foreign ministry spokesman Lin Jian, this will 'further facilitate cross-border travel in the region'. China already has visa-free travel arrangements with several countries in the region, including Singapore, Malaysia, and Thailand. Last year, the city-state and China agreed to a 30-day mutual visa-free entry for their citizens. Malaysia and Thailand also have similar agreements with China. In addition, China launched the 'Lancang-Mekong visa' scheme in November last year, offering five-year multiple-entry visas to business travellers from Cambodia, Laos, Myanmar, Thailand and Vietnam. Under this scheme, visitors can stay for up to 180 days per visit. China has been ramping up its visa-free travel arrangements with multiple countries to attract more visitors from various parts of the world. On Jun 1, China initiated a visa-free entry trial policy, allowing citizens from several Latin American countries, including Argentina, Brazil, Chile, Peru, and Uruguay. Beijing also recently extended visa-free entry to all member states of the Gulf Cooperation Council (GCC), which includes Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates. /TISG Read also: Is China finally lifting its K-pop ban? BTS company Hybe opens first office in Beijing Featured image by Depositphotos
Business Times
18 hours ago
- Business Times
Vietnam's exports and FDI pledges continue on robust growth track in May
[HO CHI MINH CITY] Vietnam's trade and foreign direct investment (FDI) continued to chart strong growth in May, driven by front-loading demand following the temporary suspension of 'Liberation Day' tariffs from the US, Vietnam's largest export market. Estimates from the government's statistics agency (NSO) on Friday (June 6) showed that exports rose by 17 per cent year on year to US$39.6 billion, down slightly from the on-year 19.8 per cent rate for April. Imports rose year on year by 14.1 per cent to US$39.04 billion, also by less than April 22.9 per cent rise on year. On a monthly basis, exports and imports grew by 5.7 per cent and 5.9 per cent, respectively. The electronics sector led exports, with a 5.2 per cent monthly increase and a 52.4 per cent year-on-year rise to US$9.2 billion. In contrast, footwear and textiles – key exports to the US – grew more modestly, by 1.9 per cent and 9.2 per cent, respectively, down from double-digit figures in April. For the January-to-May period, Vietnam recorded a trade surplus of US$4.67 billion, narrowing from US$8.71 billion in the same period of 2024, when exports and imports rose by 14 per cent and 17.4 per cent, respectively. A NEWSLETTER FOR YOU Friday, 8.30 am Asean Business Business insights centering on South-east Asia's fast-growing economies. Sign Up Sign Up Analysts expect front-loading to persist through the second quarter of 2025, with the momentum likely to ease once the US' 90-day tariff suspension expires in early July. Vietnam's industrial production remained healthy, with a 9.4 per cent year-on-year increase in May, though it eased slightly from a 9.6 per cent growth in April. Despite marking the fourth consecutive month of expansion, it was the softest gain since a contraction in January. Soft data also indicated a contraction in factory activity. The S&P Global Vietnam Purchasing Managers' Index (PMI) for May recorded its second consecutive month below the 50 threshold, reflecting a slowdown driven by declining new orders amid reduced foreign demand linked to US tariff uncertainties. Adam Ahmad Samdin, economist at Oxford Economics, also highlighted increasing downside risks to the think tank's 6.3 per cent year-on-year GDP growth forecast for the country this year. 'The authorities may not be able to come to a deal with the US due to Vietnam's inherent reliance on Chinese inputs, potentially bringing tariffs back to 46 per cent,' he said. Reliance on Chinese input In April, President Donald Trump imposed a 46 per cent 'reciprocal' tariff on Vietnam, among the highest among US trading partners. These import taxes have been temporarily reduced to 10 per cent, with a Jul 9 deadline to reach a trade deal. Reuters reported this week that Washington has sent Hanoi tough requests for tariff discussions, including demands that the South-east Asian country reduce its reliance on materials and components from China. US Secretary of Commerce Howard Lutnick said on Wednesday that there is still room for talks if Vietnam curtails imports from China and reduces its trade deficit with the US, which amounted to US$123 billion last year. However, driven by the front-loading surge in the first five months of this year, the South-east Asian country recorded a growing trade surplus with the US – US$49.9 billion, marking a 28.5 per cent year-on-year increase. Meanwhile, China continued to be the primary source of its imports, comprising 39.5 per cent of the total. This swelled Vietnam's trade deficit with China to US$45.9 billion, a 40.3 per cent increase from the year-ago period. Strong FDI from China and Singapore Realised FDI in Vietnam rose 7.9 per cent year on year to US$8.90 billion from January to May 2025, the highest in the same period in the past five years. FDI pledges hit US$18.39 billion, marking a 51.2 per cent surge from last year's figure. Singapore topped the investor list with over US$4.38 billion in registered FDI, accounting for 23.8 per cent of total foreign inflows; this was 30.1 per cent more than the year before. South Korea followed with more than US$2.93 billion, making up nearly 16 per cent of the total and marking a 2.47-time rise from the year before. In terms of new projects, mainland China remained the largest contributor, with 453 projects, up 30 per cent month on month and 2.5 times higher year on year. The value of these projects in the first five months was US$1.81 billion. Room to support growth In the domestic sector, Vietnam's retail sales advanced by 10.2 per cent year on year in May, easing from an almost two-year high of 11.1 per cent in the preceding month. Headline inflation rose by 3.2 per cent, up from 3.1 per cent in April, still below the 4.75 per cent cap imposed by the State Bank of Vietnam (SBV) . Samdin said: 'This should allow the SBV room for greater monetary easing later in the year, to achieve the ambitious 8 per cent growth target.' Meanwhile, economists at HSBC Global Research highlighted Vietnam's fiscal room to support growth, as the South-east Asian country has public debt-to-GDP ratio at around 40 per cent, the lowest in Asean. They also observed renewed commitment from the authorities to accelerating project implementation and ensuring timely completion, alongside a push to fast-track new transport and energy mega-projects. They wrote in a May 12 note: 'Vietnam is keen to continue with its old playbook of pushing for infrastructure development. (This is able to) kill two birds with one stone by supporting growth while improving infrastructure connectivity.'
Business Times
a day ago
- Business Times
Lightstone Ventures, Temasek's ClavystBio co-lead Allay Therapeutics' US$57.5 million Series D funding
[SINGAPORE] United States-based biotechnology company Allay Therapeutics on Thursday (Jun 5) announced it has raised US$57.5 million in a Series D financing round, co-led by biotech venture capital (VC) firm Lightstone Ventures and ClavystBio, a Temasek-linked life sciences venture builder. Participants in the round include the following existing investors: New Enterprise Associates, a US-based VC company; healthcare VC firm Arboretum Ventures; Temasek unit Vertex Holdings' growth-stage VC fund Vertex Growth; Vertex's healthcare fund Vertex Ventures Healthcare; and Australian life sciences VC firm Brandon Capital. New investors who joined the round were US VC firm IPD Capital; Singapore government-backed deep tech investor SGInnovate; as well as EDBI, which operates under SG Growth Capital, the investment platform of the Singapore Economic Development Board and Enterprise Singapore. Drug manufacturer Maruishi Pharmaceutical has expanded its license agreement with Allay Therapeutics to include South Korea and Taiwan, in addition to Japan. As part of this agreement, Maruishi also participated in the Series D round. Meanwhile, HSBC Innovation Banking, which focuses on banking solutions for start-ups, investors and pre-initial public offering companies, also provided additional venture debt financing to Allay Therapeutics. Founded in 2017, Allay Therapeutics, which was incubated by Lightstone Ventures' Singapore fund and The Foundry, focuses on pain relief. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Its technology is used to create analgesic products that can aid patients with post-surgical pain management and recuperation, reducing the need for opoids and improving patient recovery. The company has teams in the US and Singapore. Funds from the Series D round will support the company's registration trial, which started in February this year and involves 200 participants in multiple US sites. The trial evaluates its product for the treatment of pain after total knee replacement surgery. Results from the trial will be available in the third quarter of 2025.